miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2

por Zhao, Mingchuan, Zhang, Mengmeng, Tao, Zhonghua, Cao, Jun, Wang, Leiping, Hu, Xichun
Publicado 2020

Phase 1b clinical trial of pucotenlimab (HX008), a novel anti-PD-1 monoclonal antibody, combined with gemcitabine and cisplatin in the first-line treatment of metastatic triple-neg...

por Cao, Jun, Wang, Biyun, Zhang, Jian, Tao, Zhonghua, Wang, Leiping, Hu, Xichun
Publicado 2022

PDGFD induces ibrutinib resistance of diffuse large B-cell lymphoma through activation of EGFR

por Jin, Jia, Wang, Leiping, Tao, Zhonghua, Zhang, Jian, Lv, Fangfang, Cao, Junning, Hu, Xichun
Publicado 2020

GSTT1, GSTP1, and GSTM1 genetic variants are associated with survival in previously untreated metastatic breast cancer

por Zhang, Jian, Wu, Ying, Hu, Xichun, Wang, Biyun, Wang, Leiping, Zhang, Sheng, Cao, Jun, Wang, Zhonghua
Publicado 2017

An explorative analysis of the prognostic value of lactate dehydrogenase for survival and the chemotherapeutic response in patients with advanced triple-negative breast cancer

por Jia, Zhenya, Zhang, Jian, Wang, Zhonghua, Wang, Biyun, Wang, Leiping, Cao, Jun, Tao, Zhonghua, Hu, Xichun
Publicado 2018

Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer

por Jin, Jia, Gao, Yu, Zhang, Jian, Wang, Leiping, Wang, Biyun, Cao, Jun, Shao, Zhimin, Wang, Zhonghua
Publicado 2018

Clinical Outcomes of 130 Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Treated with Palbociclib plus Endocr...

por Liu, Chang, Li, Ting, Tao, Zhonghua, Cao, Jun, Wang, Leiping, Zhang, Jian, Wang, Biyun, Hu, Xichun
Publicado 2020

Overall survival of cancer patients with serum lactate dehydrogenase greater than 1000 IU/L

por Liu, Rujiao, Cao, Jun, Gao, Xiang, Zhang, Jian, Wang, Leiping, Wang, Biyun, Guo, Lin, Hu, Xichun, Wang, Zhonghua
Publicado 2016

Whether low-dose metronomic oral cyclophosphamide improves the response to docetaxel in first-line treatment of non-triple-negative metastatic breast cancer

por Zhang, Jian, Wang, Leiping, Wang, Zhonghua, Wang, Biyun, Cao, Jun, Lv, Fangfang, Zhang, Sheng, Shao, Zhimin, Hu, Xichun
Publicado 2017

Dalpiciclib Combined With Pyrotinib and Letrozole in Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer (LORDSHIPS): A Phase Ib Study

por Zhang, Jian, Meng, Yanchun, Wang, Biyun, Wang, Leiping, Cao, Jun, Tao, Zhonghua, Li, Ting, Yao, Wenqing, Hu, Xichun
Publicado 2022

PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib

por Wang, Leiping, Zhang, Qunling, Zhang, Jian, Sun, Si, Guo, Haiyi, Jia, Zhen, Wang, Biyun, Shao, Zhimin, Wang, Zhonghua, Hu, Xichun
Publicado 2011

Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-W...

por Li, Yi, Xie, Yizhao, Gong, Chengcheng, Zhao, Yannan, Zhang, Jian, Zhang, Sheng, Wang, Leiping, Chen, She, Hu, Xichun, Wang, Biyun
Publicado 2020

Real-World Data of Pyrotinib-Based Therapy in Metastatic HER2-Positive Breast Cancer: Promising Efficacy in Lapatinib-Treated Patients and in Brain Metastasis

por Lin, Ying, Lin, Mingxi, Zhang, Jian, Wang, Biyun, Tao, Zhonghua, Du, Yiqun, Zhang, Sheng, Cao, Jun, Wang, Leiping, Hu, Xichun
Publicado 2020

Optimal duration of prior endocrine therapy predicts the efficacy of Fulvestrant in a real‐world study for patients with hormone receptor‐positive and HER2‐negative advanced breast...

por Zhao, Yannan, Li, Yi, Gong, Chengcheng, Xie, Yizhao, Zhang, Jian, Wang, Leiping, Cao, Jun, Tao, Zhonghua, Wang, Biyun, Hu, Xichun
Publicado 2020

Exosomal annexin A6 induces gemcitabine resistance by inhibiting ubiquitination and degradation of EGFR in triple-negative breast cancer

por Li, Ting, Tao, Zhonghua, Zhu, Yihui, Liu, Xiaojia, Wang, Leiping, Du, Yiqun, Cao, Jun, Wang, Biyun, Zhang, Jian, Hu, Xichun
Publicado 2021

Comparison of two regimens of weekly paclitaxel plus gemcitabine in patients with metastatic breast cancer: propensity score–matched analysis of real-world data

por Gong, Chengcheng, Xie, Yizhao, Zhao, Yannan, Li, Yi, Zhang, Jian, Wang, Leiping, Cao, Jun, Tao, Zhonghua, Hu, Xichun, Wang, Biyun
Publicado 2022

Analysis of clinical features, genomic landscapes and survival outcomes in HER2-low breast cancer

por Jin, Juan, Li, Bin, Cao, Jianing, Li, Ting, Zhang, Jian, Cao, Jun, Zhao, Mingchuan, Wang, Leiping, Wang, Biyun, Tao, Zhonghua, Hu, Xichun
Publicado 2023

Phase II Study of Pseudomonas aeruginosa-Mannose-Sensitive Hemagglutinin in Combination with Capecitabine for Her-2–Negative Metastatic Breast Cancer Pretreated with Anthracycline...

por Lv, Fangfang, Cao, Jun, Liu, Zhebin, Wang, Zhonghua, Zhang, Jian, Zhang, Sheng, Wang, Leiping, Zhao, Xinmin, Shao, Zhimin, Wang, Biyun, Hu, Xichun
Publicado 2015

Chemotherapy of metastatic triple negative breast cancer: Experience of using platinum-based chemotherapy

por Zhang, Jian, Fan, Minhao, Xie, Jie, Wang, Zhonghua, Wang, Biyun, Zhang, Sheng, Wang, Leiping, Cao, Jun, Tao, Zhonghua, Li, Ting, Hu, Xichun
Publicado 2015

A randomized phase II study of aromatase inhibitors plus metformin in pre-treated postmenopausal patients with hormone receptor positive metastatic breast cancer

por Zhao, Yannan, Gong, Chengcheng, Wang, Zhonghua, Zhang, Jian, Wang, Leiping, Zhang, Sheng, Cao, Jun, Tao, Zhonghua, Li, Ting, Wang, Biyun, Hu, Xichun
Publicado 2017